|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 12000665.5 (espacenet) (Federated) (European Patent Register), 20090602 | | Patent/reg. no. and date | DK/EP 2491942, 20131023 | | Publication date | 20120829 | | Priority no. and date | WO PCT/EP2008/004341, 20080530 | | EP pub. no. and date |
EP 2491942 20120829 | | Effective date | | | Applicant/owner | Xigen Inflammation Ltd., Arch. Makariou III
195 Neocleous House
3030 Limassol, CY | | Applicant ref. no. | 157857 | | Inventor | Bonny, Christophe, 37c, chemin du Trabandan
1006 Lausanne, CH | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , A61P 9/00 (2006.01) , C07K 14/47 (2006.01) , C07K 14/81 (2006.01) | | Title | Anvendelse af cellepermeable peptidinhibitorer af JNK-signaltransduktionsvejen til behandling af forskellige kardiovaskulære sygdomme. | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
